61 – 67 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Cancer risks in BRCA2 mutation carriers
- Contribution to journal › Article
- 1998
-
Mark
Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor
Bratt, O LU ; Kristoffersson, U LU ; Olsson, Håkan LU
and Lundgren, R
(1998)
In European Urology
34(1).
p.19-24
- Contribution to journal › Article
-
Mark
Forskningsframsteg om hereditär prostatacancer. Riskfamiljer bör kartläggas och erbjudas screening
Bratt, O LU ; Abrahamsson, P A LU ; Lundgren, R ; Olsson, Håkan LU
and Kristoffersson, U
LU
(1998)
In Läkartidningen
95(14).
p.6-1494
- Contribution to journal › Article
-
Mark
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./Ml. Prostate specific antigen
Lodding, P. ; Aus, G. ; Bergdahl, S. ; Frösing, R. ; Lilja, H. LU
; Pihl, C. G.
and Hugosson, J.
(1998)
In Journal of Urology
159(3).
p.899-903
- Contribution to journal › Article
- 1997
-
Mark
The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer : a population-based cohort study
Bratt, O LU ; Kristoffersson, U LU ; Lundgren, R and Olsson, Håkan LU
(1997)
In European Journal of Cancer
33(13).
p.2237-2240
- Contribution to journal › Article
-
Mark
Sons of men with prostate cancer : their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing
Bratt, O LU ; Kristoffersson, U LU ; Lundgren, Rolf and Olsson, Håkan LU
(1997)
In Urology
50(3).
p.5-360
- Contribution to journal › Article
- 1996
-
Mark
A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates : The best case scenario
Prestigiacomo, Anthony F. ; Lilja, Hans LU
; Pettersson, Kim
; Wolfert, Robert L.
and Stamey, Thomas A.
(1996)
In Journal of Urology
156(2).
p.350-354
- Contribution to journal › Article